Sarah Leonard1, Merlin Pereira1, Richard Fox2, Naheema Gordon1, Jason Yap1, Sean Kehoe1, David Luesley1, Ciaran Woodman1, Raji Ganesan3. 1. Institute of Cancer and Genomic Sciences, College of Dental and Medical School, University of Birmingham, Edgbaston B15 2TT, United Kingdom. 2. Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston B15 2TT, United Kingdom. 3. Birmingham Women's NHS Foundation Trust, Mindelsohn Way, Edgbaston, Birmingham B15 2TG, United Kingdom. Electronic address: Raji.Ganesan@bwnft.nhs.uk.
Abstract
OBJECTIVE: Cancer initiation and progression has been linked to aberrant expression of the DNA methyltransferases (DNMT), the enzymes which establish and maintain DNA methylation patterns throughout the genome. In this study, we investigated if DNMT expression in vulvar squamous cell carcinomas (VSCC) was related to clinical outcome. METHODS: DNMT1, DNMT3A and DNMT3B expression was measured in a subset of cases drawn from a cohort of consecutive women treated for primary VSCC at the Pan Birmingham Gynaecological Cancer Centre between 2001 and 2008. Univariable and multivariable competing risk modelling was performed to identify whether DNMT expression was associated with local disease recurrence or disease morbidity. RESULTS: Over-expression of DNMT3A in the invasive component of the tumour was seen in 44% of tumours and was associated with an increased risk of local vulvar recurrence (LVR) (HR=4.51, p=0.012). This risk was found to increase further after adjustment for disease stage (HR=6.00, p=0.003) and groin node metastasis (HR=4.81, p=0.008). Over-expression of DNMT3B was associated with an increased risk of LVR (HR=5.69 p=0.03), however this ceased to be significant after adjustment for groin node metastasis. In a subset analysis, over-expression of DNMT3A was found to be significantly more common in VSCCs that stained negative for CDKN2A. CONCLUSIONS: These observations are consistent with the possibility that epigenetic changes contribute to vulvar neoplasia and DNMT3A over-expression may be useful in predicting local disease recurrence.
OBJECTIVE:Cancer initiation and progression has been linked to aberrant expression of the DNA methyltransferases (DNMT), the enzymes which establish and maintain DNA methylation patterns throughout the genome. In this study, we investigated if DNMT expression in vulvar squamous cell carcinomas (VSCC) was related to clinical outcome. METHODS:DNMT1, DNMT3A and DNMT3B expression was measured in a subset of cases drawn from a cohort of consecutive women treated for primary VSCC at the Pan Birmingham Gynaecological Cancer Centre between 2001 and 2008. Univariable and multivariable competing risk modelling was performed to identify whether DNMT expression was associated with local disease recurrence or disease morbidity. RESULTS: Over-expression of DNMT3A in the invasive component of the tumour was seen in 44% of tumours and was associated with an increased risk of local vulvar recurrence (LVR) (HR=4.51, p=0.012). This risk was found to increase further after adjustment for disease stage (HR=6.00, p=0.003) and groin node metastasis (HR=4.81, p=0.008). Over-expression of DNMT3B was associated with an increased risk of LVR (HR=5.69 p=0.03), however this ceased to be significant after adjustment for groin node metastasis. In a subset analysis, over-expression of DNMT3A was found to be significantly more common in VSCCs that stained negative for CDKN2A. CONCLUSIONS: These observations are consistent with the possibility that epigenetic changes contribute to vulvar neoplasia and DNMT3A over-expression may be useful in predicting local disease recurrence.
Authors: Sebastian Zięba; Anne-Floor W Pouwer; Artur Kowalik; Kamil Zalewski; Natalia Rusetska; Elwira Bakuła-Zalewska; Janusz Kopczyński; Johanna M A Pijnenborg; Joanne A de Hullu; Magdalena Kowalewska Journal: Int J Mol Sci Date: 2020-07-10 Impact factor: 5.923
Authors: Nikki B Thuijs; Johannes Berkhof; Müjde Özer; Sylvia Duin; Annina P van Splunter; Barbara C Snoek; Daniëlle A M Heideman; Marc van Beurden; Renske D M Steenbergen; Maaike C G Bleeker Journal: Int J Cancer Date: 2021-01-10 Impact factor: 7.396
Authors: Jason Yap; Richard Fox; Natalie Narsia; Sonia Pinheiro-Maia; Rachel Pounds; Ciaran Woodman; David Luesley; Raji Ganesan; Sean Kehoe; Christopher Dawson Journal: PLoS One Date: 2018-10-31 Impact factor: 3.240
Authors: Katharina Prieske; Malik Alawi; Anna Jaeger; Maximilian Christian Wankner; Kathrin Eylmann; Susanne Reuter; Patrick Lebok; Eike Burandt; Niclas C Blessin; Barbara Schmalfeldt; Leticia Oliveira-Ferrer; Simon A Joosse; Linn Woelber Journal: Cancers (Basel) Date: 2021-12-19 Impact factor: 6.639